Results 1 to 10 of about 882,069 (246)

Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers. [PDF]

open access: yesPLoS ONE, 2011
The CA 19-9 assay detects a carbohydrate antigen on multiple protein carriers, some of which may be preferential carriers of the antigen in cancer. We tested the hypothesis that the measurement of the CA 19-9 antigen on individual proteins could improve ...
Tingting Yue   +13 more
doaj   +2 more sources

Diagnostic Value of CA 19-9 and Carcinoembryonic Antigen for Pancreatic Cancer: A Meta-Analysis

open access: yesGastroenterology Research and Practice, 2018
Background. CA 19-9 and carcinoembryonic antigen (CEA) are widely used for the diagnosis of pancreatic cancer. The purpose of the present study was to compare the diagnostic value of CA 19-9 with CEA for pancreatic cancer. Methods.
Haibo Xing   +6 more
doaj   +3 more sources

The prognostic value of postoperative tumor marker conversion for gastric cancer [PDF]

open access: yesKorean Journal of Clinical Oncology, 2020
Purpose Preoperative positivity of serum tumor markers has been associated with poor long-term survival among patients with gastric cancer. However, there have been a considerable number of patients who have experienced a normalization of tumor markers ...
Jeongju Noh, Ki Bum Park, Oh Kyoung Kwon
doaj   +1 more source

CA 19-9 and carcinoembryonic antigen in pancreatic cancer diagnosis [PDF]

open access: yesCancer, 1986
CA 19-9 (Centocor, Malvern, PA) and carcinoembryonic antigen (CEA), two recently developed immunoradiometric assays utilizing monoclonal antibodies, were evaluated in the sera of 139 subjects in order to assay their individual and combined value in pancreatic cancer diagnosis and to assess the influence of jaundice.
DEL FAVERO G.   +9 more
openaire   +3 more sources

CA 19-9 in Ovarian Immature Teratoma- A Potential Tumour Marker or A Masquerade? [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2022
Carbohydrate antigen 19-9, also known as Cancer Antigen (CA 19-9) is a tumour marker found elevated in certain ovarian tumours. Although, reports of its association with mature teratoma are considerable, little is mentioned about its association with ...
Julie H John   +4 more
doaj   +1 more source

Prognostic value of carcinoembryonic antigen and carbohydrate antigen 19–9 in periampullary cancer patients receiving pancreaticoduodenectomy

open access: yesAsian Journal of Surgery, 2021
Background: We assessed the use of serum concentrations of carbohydrate antigen (CA) 19–9 and carcinoembryonic antigen (CEA) measured during the preoperative diagnostic workup as prognostic factors for survival in patients with periampullary carcinoma ...
Sang Hun Park   +3 more
doaj   +1 more source

Prognostic Value of Carcinoembryonic Antigen (CEA) and Carbohydrate Antigen 19-9 (CA 19-9) in Gallbladder Cancer; 65 IU/mL of CA 19-9 Is the New Cut-Off Value for Prognosis [PDF]

open access: yesCancers, 2021
Due to the lack of appropriate tumor markers with optimal cut-off values to predict the prognosis of gallbladder cancer (GBC), this study aimed to demonstrate the relationship between prognosis and the levels of carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9), and to determine optimal thresholds.
Myongjin Kim   +6 more
openaire   +3 more sources

Clinicopathological Characteristics and Prognosis of Diffuse Large B-Cell Lymphoma in Relation to CA-125 and CA 19-9 Expression

open access: yesJournal of Evidence-Based Integrative Medicine, 2023
Background: Some epithelial tumors express the carbohydrate antigen 125 (Cancer antigen-125, CA-125) and CA 19-9, especially ovarian and pancreatic tumors.
Abd AlRahman Mohammad Foda MD   +5 more
doaj   +1 more source

Elevated Carbohydrate Antigen 19-9 (CA 19-9) in Patients with Echinococcus Infection [PDF]

open access: yesClinical Chemistry and Laboratory Medicine, 2001
The carbohydrate antigen 19-9 (CA 19-9), a determinant (sialylated lacto-N-fucopentaose 119) of a circulating oligosaccharide antigen, is a frequently used tumor marker. Echinococcus spp. infects humans throughout the world and may be able to synthesize closely related molecules which could interfere with the measurement and interpretation of CA 19-9 ...
Pfister, M   +4 more
openaire   +3 more sources

Pancreatic Tuberculosis with Markedly Elevated CA 19-9 Levels: A Diagnostic Pitfall

open access: yesOman Medical Journal, 2016
Despite the high prevalence of tuberculosis (TB) in developing countries, isolated pancreatic TB is rare and is usually seen in immunocompromised patients.
Manveen Kaur   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy